Clinical trial Recruiting at 2 sites Observational Ages 6 and up

Monitoring patients receiving regenerative medicine treatments for musculoskeletal diseases

Official title: Patients-reported Outcome Measures (PROMs), Clinical Objective and Biomolecular Assessment for the Monitoring of Patients Undergoing Regenerative Medicine Treatments with Orthobiologics

Run by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · NCT04711551 · Data updated 2026-11-12

This study is testing how well regenerative medicine treatments, like platelet-rich plasma, work for people with musculoskeletal diseases by collecting and tracking their health data before, during, and after treatment.

More Musculoskeletal Disease trials

Quick facts

Study typeObservational
Ages6 Years and up
SexAll
Enrollment2000 (estimated)
SponsorI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Academic / other
Locations2 sites (Milan, Italia and 1 other locations)
StatusRecruiting
StartedMay 30, 2018
Main results expectedMay 30, 2030
Study endsMay 30, 2030
Registry record updatedFebruary 17, 2025
Trial IDNCT04711551 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients aged 6 years and older with specific musculoskeletal conditions such as osteoarthritis or tendon pain.

Probably not a fit

Patients under 6 years of age or those who are not compliant with post-treatment monitoring procedures may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to enhance the evaluation of outcomes for patients undergoing regenerative medicine treatments at participating centers. It focuses on collecting objective clinical data, patient-reported outcome measures (PROMs), and biomolecular evaluations before, during, and after treatment. The study utilizes advanced software to streamline data collection and analysis, ensuring comprehensive monitoring of treatment efficacy. The interventions include the use of platelet-rich plasma (PRP) and other related devices to obtain platelet concentrates from various sources.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment outcomes and personalized care for patients with musculoskeletal conditions.

How similar studies have gone: Other studies have shown promise in using similar monitoring approaches in regenerative medicine, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients who received indication for regerative medicine treatment for one of the following pathologies: Knee or hip or ankle osteoarthritis, patellar or Achilles tendon pain, shouder or elbow pain;
* males and females;
* age \>= 6 years.

Exclusion Criteria:

* age \< 6 years
* patients not compliant with post-treatment monitoring procedures
* pregnancy

Where it's running

  • Istituto Clinico San Siro (satellite center)
    Milan, Italia, Italy
    Recruiting
  • IRCCS Ospedale Galeazzi-Sant'Ambrogio (coordinator)
    Milan, Italy, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.